Produced in the pituitary gland, -MSH is the body's primary trigger for melanogenesisthe complex process of producing melanin, the pigment that gives color to our skin, hair, and eyes
This resource includes hand-crafted patent highlights featuring synthetically lethal Pol inhibitors from linkedin_mention(urn:li:organization:1603|AstraZeneca) and linkedin_mention(urn:li:organization:1399|GSK) , SARM1 Inhibitors for neurodegenerative indications and our best guess at the identity of linkedin_mention(urn:li:organization:163993|Gilead Sciences) ' small molecule GLP-1R agonist GS-4571 Full article | Drug Hunter's 2023 Patent Review of GLP-1R Agonists June 2024 Patent Highlights: GLP-1R Agonists, Pol Inhibitors, Non-Ab PD-L1 Inhibitors and More
MSM has been shown to exhibit anti-inflammatory, antioxidant, and anti-cancer activity
Dihexa Is a synthetic oligopeptide drug that is being studied for its potential to treat neurodegenerative diseases, particularly Alzheimers disease
It's composed of the two amino acids lysine and methionine
J., Li, Y., Lahiri, D
